Literature DB >> 15302771

The relationship between asthma and COPD. Lessons from transgenic mice.

Jack Elias1.   

Abstract

Asthma is characterized by eosinophilic and mononuclear cell infiltration, mucous metaplasia, airway remodeling, reversible airflow obstruction, and airway hyperresponsiveness. COPD is typified by nonreversible or incompletely reversible airway obstruction, often accompanied by mucous metaplasia and alveolar destruction. There is considerable overlap in pathogenesis and clinical features between the conditions. However, asthma and COPD may be distinguished by their respective cytokine profiles. Studies in transgenic mice have illuminated the roles of the T helper (Th) 1-mediated cytokine interferon-gamma in COPD, supporting the British hypothesis, and the Th2-mediated cytokine interleukin-13 in asthma, supporting the Dutch hypothesis. COPD and asthma may represent disease states along a continuum, with varying degrees of each disease often present in the same patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302771     DOI: 10.1378/chest.126.2_suppl_1.111S

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study.

Authors:  Bart van Hartingsveldt; Ivo P Nnane; Esther Bouman-Thio; Matthew J Loza; Alexa Piantone; Hugh M Davis; Kevin J Petty
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

2.  Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β.

Authors:  Hideya Kitamura; Stephanie Cambier; Sangeeta Somanath; Tyren Barker; Shunsuke Minagawa; Jennifer Markovics; Amanda Goodsell; Jean Publicover; Louis Reichardt; David Jablons; Paul Wolters; Arthur Hill; James D Marks; Jianlong Lou; Jean-Francois Pittet; Jack Gauldie; Jody Lynn Baron; Stephen L Nishimura
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

3.  Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-γ.

Authors:  Byung-Jae Lee; Hyung-Geun Moon; Tae-Seop Shin; Seong Gyu Jeon; Eun-Young Lee; Yong Song Gho; Chun Geun Lee; Zhou Zhu; Jack A Elias; Yoon-Keun Kim
Journal:  Exp Mol Med       Date:  2011-04-30       Impact factor: 8.718

4.  Profiling serum biomarkers in patients with COPD: associations with clinical parameters.

Authors:  Victor Pinto-Plata; John Toso; Kwan Lee; Daniel Park; John Bilello; Hana Mullerova; Mary M De Souza; Rupert Vessey; Bartolome Celli
Journal:  Thorax       Date:  2007-03-13       Impact factor: 9.139

Review 5.  Building better mouse models of asthma.

Authors:  Clare M Lloyd
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

Review 6.  Vitamin D deficiency and chronic lung disease.

Authors:  Christopher R Gilbert; Seth M Arum; Cecilia M Smith
Journal:  Can Respir J       Date:  2009 May-Jun       Impact factor: 2.409

7.  Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways.

Authors:  Yunxiang Zhu; Camille Ehre; Lubna H Abdullah; John K Sheehan; Michelle Roy; Christopher M Evans; Burton F Dickey; C William Davis
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

8.  The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly.

Authors:  Amir A Zeki; Michael Schivo; Andrew Chan; Timothy E Albertson; Samuel Louie
Journal:  J Allergy (Cairo)       Date:  2011-10-30

Review 9.  Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs.

Authors:  Gabriele Grunig; Aram Baghdassarian; Sung-Hyun Park; Serhiy Pylawka; Bertram Bleck; Joan Reibman; Erika Berman-Rosenzweig; Nedim Durmus
Journal:  Biomark Insights       Date:  2016-02-16

Review 10.  [COPD: An early disease].

Authors:  V Margelidon-Cozzolino; K Chbini; N Freymond; G Devouassoux; A Belaaouaj; Y Pacheco
Journal:  Rev Pneumol Clin       Date:  2015-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.